Drugs Made In America Acquisition II Corp. Ordinary Shares (DMII) Stock Ticker
DMII right now
Market factors today
Unlock the full DMII picture
About Drugs Made In America Acquisition II Corp. Ordinary Shares
Drugs Made In America Acquisition II Corp. currently lacks significant business operations. Its core objective is to execute a business combination, which may take various forms such as a merger, an acquisition of assets or shares, a recapitalization, or a reorganization, with one or more other entities. The company was founded in 2024 and maintains its principal office in Fort Lauderdale, Florida.
DMII stock facts
| Ticker symbol | DMII |
| Exchange | NASDAQ Global Market |
| Sector | Financial Services |
| Industry | Financial - Conglomerates |
| Market cap | $647.2M |
| CEO | Roger Bendelac |
| Employees | 2 |
| Headquarters | New York, NY, US |
| IPO date | 2025-12-04 |
| Website | dmaacorp.com |
What you can see for DMII on Tickr
Live DMII price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the DMII report.
Rankings
FAQ
What is the ticker symbol for Drugs Made In America Acquisition II Corp. Ordinary Shares?
The ticker symbol for Drugs Made In America Acquisition II Corp. Ordinary Shares is DMII, listed on the NASDAQ Global Market.
What is DMII?
Drugs Made In America Acquisition II Corp. currently lacks significant business operations. Its core objective is to execute a business combination, which may take various forms such as a merger, an acquisition of assets or shares, a recapitalization, or a reorganization, with one or more other entities. The company was founded in 2024 and maintains its principal office in Fort Lauderdale,…